News

Editor's picks

Paediatric adrenocortical tumours are a biologically diverse group of diseases that can be divided into clinically distinct subtypes using proteomic profiling, say German researchers.
Patients with congenital adrenal hyperplasia are significantly more likely to be admitted to hospital and experience severe in-hospital outcomes than people without the condition, especially during the first years of life, highlight Swiss researchers.
Simvastatin treatment has not significantly improved growth in a randomised phase 3 trial of children with Noonan syndrome (NS), French researchers report in eClinicalMedicine.

Latest headlines

Paediatric adrenocortical tumours are a biologically diverse group of diseases that can be divided into clinically distinct subtypes using proteomic profiling, say German researchers.
Testicular dysfunction after treatment for childhood haematological malignancy is “mostly reversible” but warrants long-term endocrine surveillance in survivors, Argentinian researchers say.
Patients with congenital adrenal hyperplasia are significantly more likely to be admitted to hospital and experience severe in-hospital outcomes than people without the condition, especially during the first years of life, highlight Swiss researchers.
Simvastatin treatment has not significantly improved growth in a randomised phase 3 trial of children with Noonan syndrome (NS), French researchers report in eClinicalMedicine.
Temple syndrome (TS14) has a broader range of phenotypic features than previously recognised and the presentation may change with increasing age, indicates an analysis of children attending two European referral centres.
The TRANSECEND trial confirms that the melanocortin-4 receptor agonist setmelanotide achieves a significantly greater reduction in BMI and hunger than placebo in children, adolescents and adults with acquired hypothalamic obesity.
The Endocrine Society has published a clinical practice guideline on the diagnosis and treatment of children with central precocious puberty in The Journal of Clinical Endocrinology & Metabolism.
International guidance has been published on managing the transition of children with endocrine disorders from paediatric to adult services, and on the use of genetic testing in children with short stature.
Islet autoantibody screening for early-stage type 1 diabetes in children is feasible in the general population, the Fr1da study investigators have found.
Burosumab treatment for X-linked hypophosphataemia may begin in the first year of life, suggest phase 2 trial findings published in The Lancet Diabetes & Endocrinology.
Basket trial findings indicate that vosoritide therapy may improve growth in children with short stature related to rare genetic disorders of the Ras–mitogen-active protein kinase pathway.
UK study findings indicate that a slow-release formulation of the gonadotropin-releasing hormone analogue triporelin given every 24 weeks is as effective as the standard 12-weekly treatment for central precocious puberty.
Sign up for eAlerts
Be the first to hear about new resources and content by signing up to receive our eAlerts.

We'd love your feedback!

Please complete this short 5-question survey to help improve the content offered on this website.
Please rank the following aspects of the program from best [1] to worst [4].